Both in Pharmaceuticals
Akebia Therapeutics vs Entrada Therapeutics
Over the past year AKBA returned −66.1% and TRDA returned −30.2%; their daily moves had a correlation of 0.45.
AKBA −66.1% TRDA −30.2%Growth of $1, one year, split-adjusted
| Metric | AKBA | TRDA |
|---|---|---|
| Price | $0.7177 | $4.73 |
| Market cap | $198.9M | $184.2M |
| Today | +1.32% | −7.44% |
| 1 month | −21.2% | −13.7% |
| 6 months | −50.5% | −70.0% |
| Year to date | −55.4% | −54.0% |
| 1 year | −67.5% | −31.9% |
| Revenue growth (YoY) | −21.4% | −53.9% |
| Gross margin | 78.8% | 100.0% |
| Net margin | −18.1% | −4762.0% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 39.3× |
| Net cash | $106.0M | $223.0M |
| Dividend yield | — | — |
| Volatility (60d) | 71.9% | 84.8% |
| Short % of float | 8.7% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).